Top compounds associated with response to DLX1


Feature Type Standardized
Nominal ANOVA
mRNA foretinib CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ZG-10 GDSC1000 pan-cancer AAC 0.14 0.001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.1 0.001
mRNA GSK429286A GDSC1000 pan-cancer AAC 0.1 0.001
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.099 0.002
mRNA COL-3 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Topotecan CTRPv2 pan-cancer AAC 0.1 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV